Cardiology

A phase 2 clinical trial found that ataciguat, a soluble guanylate cyclase activator, may slow aortic valve calcification and help preserve cardiac function in patients with moderate calcific aortic valve...

An artificial intelligence–enabled electrocardiogram (AI-ECG) accurately detected diastolic dysfunction and elevated filling pressure in patients with hypertrophic cardiomyopathy and cardiac amyloidosis,...

A large U.S. cohort study presented at the American Heart Association Scientific Sessions found that middle-aged adults with low HDL cholesterol levels ( 50 mg/dL) faced a 33% higher risk of developing...

As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...

Late-window alteplase improved 90-day independence in perfusion-selected ischemic stroke, with higher symptomatic intracranial hemorrhage and no mortality difference.

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...

Excess visceral fat, rather than BMI alone, is a key driver of cardiovascular risk in people with HIV receiving antiretroviral therapy. The study authors presented their findings at the Conference on...

In this expert interview, Deepak L. Bhatt, MD, MPH discusses guideline-based and emerging strategies for reducing recurrent ischemic stroke risk. From dietary interventions and blood pressure control to...

Anticoagulation after trauma reduces the risk of stroke and transient ischemic attacks without significantly increasing bleeding or readmissions, according to the results of a study presented at the Society...

Preoperative diastolic dysfunction significantly elevates the risk of major adverse cardiac events and long-term mortality in patients undergoing hip fracture surgery, according to a retrospective cohort...